Medicare Enrolled
Dr. Fardin Djafari, M.D.
Cardiovascular Disease · Wichita Falls, TX
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Djafari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Djafari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Djafari
Dr. Fardin Djafari is a cardiovascular disease specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Djafari performed 4,405 Medicare services across 3,549 unique beneficiaries.
Between the years covered by Open Payments, Dr. Djafari received a total of $6,716 from 36 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Djafari is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in TX
$6,716 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,405
Medicare services
Top 21% in TX for cardiovascular disease
3,549
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,218 | $86 | $275 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
791 | $10 | $75 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
353 | $151 | $706 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
280 | $138 | $1,188 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $54 | $190 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
169 | $47 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
163 | $41 | $125 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
133 | $47 | $475 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
121 | $126 | $240 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
108 | $19 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $118 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
86 | $133 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
86 | $62 | $135 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
85 | $22 | $95 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
82 | $93 | $250 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
79 | $80 | $282 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
48 | $6 | $45 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
39 | $27 | $135 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $74 | $275 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
32 | $9 | $80 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
30 | $17 | $155 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
29 | $28 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $134 | $375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $102 | $250 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
18 | $53 | $150 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
14 | $89 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
12 | $17 | $78 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
12 | $11 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.6% high complexity
20.3% medium
70.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,716
Total received (2018-2024)
Avg $959/year across 7 years
Top 41% in TX for cardiovascular disease
36
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,716 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,612
2023
$744
2022
$1,122
2021
$719
2020
$471
2019
$857
2018
$1,190
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$917
ABIOMED
$682
Boehringer Ingelheim Pharmaceuticals, Inc.
$608
Janssen Pharmaceuticals, Inc
$606
PFIZER INC.
$462
Amgen Inc.
$452
E.R. Squibb & Sons, L.L.C.
$432
Merck Sharp & Dohme LLC
$289
Abbott Laboratories
$285
Edwards Lifesciences Corporation
$241
Astellas Pharma US Inc
$231
Amarin Pharma Inc.
$186
SANOFI-AVENTIS U.S. LLC
$150
Gilead Sciences, Inc.
$136
AstraZeneca Pharmaceuticals LP
$136
Regeneron Healthcare Solutions, Inc.
$129
HeartFlow, Inc.
$126
Merck Sharp & Dohme Corporation
$101
Philips Electronics North America Corporation
$92
Boston Scientific Corporation
$83
Kiniksa Pharmaceuticals International, plc
$51
CHIESI USA, INC.
$43
Bayer HealthCare Pharmaceuticals Inc.
$35
Relypsa, Inc.
$32
Allergan Inc.
$25
Inari Medical, Inc.
$24
SpectraWAVE, Inc
$23
Esperion Therapeutics, Inc.
$21
Novo Nordisk Inc
$21
Philips North America LLC
$16
Medtronic Vascular, Inc.
$14
ShockWave Medical, Inc
$14
ATRICURE, INC.
$14
ARALEZ PHARMACEUTICALS US INC.
$13
Inspire Medical Systems, Inc.
$13
United Therapeutics Corporation
$13
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · ATRICLIP LAA EXCLUSION SYSTEM · Arcalyst · Assurity Pacemaker · BRILINTA · BYSTOLIC · BodyGuardian · CAMZYOS · CHANTIX · CONFIRM RX · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Endurant · FARXIGA · FFRct · FLOWTRIEVER CATHETER · GALLANT · HyperVue Imaging System · INSPIRE · Impella · JARDIANCE · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · Lexiscan · MULTAQ · NEXLETOL · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · S · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VantageView System · Vascepa · Vascular Lithotripsy · Veltassa · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $152 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
8
Per 100K population
6.2
County median income
$62,168
Nearest hospital
UNITED REGIONAL HEALTH CARE SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Djafari is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Djafari experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Djafari performed 1,218 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Djafari receive payments from pharmaceutical companies?
Yes. Dr. Djafari received a total of $6,716 from 36 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Djafari's costs compare to other cardiologists in Wichita Falls?
Dr. Djafari's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Djafari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Wichita Falls
Browse cardiologists in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology